Literature DB >> 31321674

Whole-exome sequencing of familial esophageal squamous cell carcinoma identified rare pathogenic variants in new predisposition genes.

F F Golyan1,2, T E Druley3, M R Abbaszadegan4,5.   

Abstract

PURPOSE: Esophageal squamous cell carcinoma (ESCC) is one of the most important causes of mortality in the developing world. Although hereditary forms arise from germ-line mutations in TP53, Rb, and the mismatch repair genes, many familial cases present with an unknown inherited cause. The new theory of rare, high-penetrance mutations in less known genes is a likely explanation for the underlying predisposition in some of these familial cases.
METHODS: Exome sequencing was performed in 9 patients with esophageal squamous cancer from 9 families with strong disease aggregation without mutations in known hereditary esophageal cancer genes. Data analysis was limited to only really rare variants (0-0.01%), producing a putative loss of function and located in genes with a role compatible with carcinogenesis.
RESULTS: Twenty-two final candidate variants were selected and validated by Sanger sequencing. Correct family segregation and somatic studies were used to categorize the most interesting variants in CDK11A, ARID1A, JMJD6, MAML3, CDKN2AIP, and PHLDA1.
CONCLUSION: Together, we identified new potential esophageal squamous cancer predisposition variants in genes which may have a role in cancer and are involved in chromatin remodeling and cell-cycle pathway, which could increase the risk of ESCC.

Entities:  

Keywords:  ESCC; Genetic variant; Hereditary disease; Next-generation sequencing; Signaling pathway

Mesh:

Year:  2019        PMID: 31321674     DOI: 10.1007/s12094-019-02174-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  32 in total

1.  Interaction of JMJD6 with single-stranded RNA.

Authors:  Xia Hong; Jianye Zang; Janice White; Chao Wang; Cheol-Ho Pan; Rui Zhao; Robert C Murphy; Shaodong Dai; Peter Henson; John W Kappler; James Hagman; Gongyi Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

Review 2.  Cancers with increasing incidence trends in the United States: 1999 through 2008.

Authors:  Edgar P Simard; Elizabeth M Ward; Rebecca Siegel; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

3.  p53 mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): a high-incidence area.

Authors:  Mohammad Muzaffar Mir; Nazir Ahmad Dar; Sailesh Gochhait; Showkat Ali Zargar; Abdul Gani Ahangar; R N K Bamezai
Journal:  Int J Cancer       Date:  2005-08-10       Impact factor: 7.396

Review 4.  SWI/SNF nucleosome remodellers and cancer.

Authors:  Boris G Wilson; Charles W M Roberts
Journal:  Nat Rev Cancer       Date:  2011-06-09       Impact factor: 60.716

5.  Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors.

Authors:  Lizi Wu; Tao Sun; Karla Kobayashi; Ping Gao; James D Griffin
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

Review 6.  Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer.

Authors:  Masaru Katoh
Journal:  Cancer Biol Ther       Date:  2007-03-26       Impact factor: 4.742

7.  JMJD6 is a histone arginine demethylase.

Authors:  Bingsheng Chang; Yue Chen; Yingming Zhao; Richard K Bruick
Journal:  Science       Date:  2007-10-19       Impact factor: 47.728

8.  Lysyl 5-hydroxylation, a novel histone modification, by Jumonji domain containing 6 (JMJD6).

Authors:  Motoko Unoki; Akiko Masuda; Naoshi Dohmae; Kyohei Arita; Masanori Yoshimatsu; Yukiko Iwai; Yoshinori Fukui; Koji Ueda; Ryuji Hamamoto; Masahiro Shirakawa; Hiroyuki Sasaki; Yusuke Nakamura
Journal:  J Biol Chem       Date:  2013-01-09       Impact factor: 5.157

9.  Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing.

Authors:  Celia J Webby; Alexander Wolf; Natalia Gromak; Mathias Dreger; Holger Kramer; Benedikt Kessler; Michael L Nielsen; Corinna Schmitz; Danica S Butler; John R Yates; Claire M Delahunty; Phillip Hahn; Andreas Lengeling; Matthias Mann; Nicholas J Proudfoot; Christopher J Schofield; Angelika Böttger
Journal:  Science       Date:  2009-07-03       Impact factor: 47.728

10.  JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation.

Authors:  Feng Wang; Lin He; Peiwei Huangyang; Jing Liang; Wenzhe Si; Ruorong Yan; Xiao Han; Shumeng Liu; Bin Gui; Wanjin Li; Di Miao; Chao Jing; Zhihua Liu; Fei Pei; Luyang Sun; Yongfeng Shang
Journal:  PLoS Biol       Date:  2014-03-25       Impact factor: 8.029

View more
  3 in total

1.  IGFBP7 remodels the tumor microenvironment of esophageal squamous cell carcinoma by activating the TGFβ1/SMAD signaling pathway.

Authors:  Xiuqing Li; Ji Zhang; Youshan Wu; Chuntao Ma; Dongying Wei; Lijuan Pan; Liangliang Cai
Journal:  Oncol Lett       Date:  2022-06-10       Impact factor: 3.111

2.  Genomic analyses reveal SCN7A is associated with the prognosis of esophageal squamous cell carcinoma.

Authors:  Ping Yuan; Wenqing Rao; Zheng Lin; Shuang Liu; Xiuquan Lin; Chaofeng Wu; Xu Lin; Zhijian Hu; Weimin Ye
Journal:  Esophagus       Date:  2022-01-07       Impact factor: 3.671

Review 3.  Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response.

Authors:  Kai Wang; Chao Yang; Haibin Li; Xiaoyan Liu; Meiling Zheng; Zixue Xuan; Zhiqiang Mei; Haiyong Wang
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.